CRISPR Therapeutics AG (CRSP) Cash Flow Quarterly - Discounting Cash Flows
CRSP
CRISPR Therapeutics AG
CRSP (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
Report Filing: 2025-11-10 2025-11-10 2025-08-04 2025-05-06 2025-02-11 2024-11-05 2024-08-05
1234
Net Income/Starting Line -488.3 -106.4 -208.5 -136 -37.31 -85.94 -126.4
1234
Cash From Operating Activities -302.5 -84.63 -113.9 -53.95 -50.03 -106.9 -95.58
1234
Depreciation and Amortization 18.66 4.43 4.65 4.74 4.84 4.74 4.84
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 76.37 16.6 17.61 20.21 21.95 21.54 23.67
1234
Other Non-Cash Items 65.88 -10.14 88.92 2.25 -15.15 -6.9 -8.18
1234
Changes in Working Capital 24.89 10.91 -16.51 54.85 -24.35 -40.36 10.49
1234
Accounts Receivable 0 0 0 25 -25 0 0
1234
Inventory 0 0 0 0 0 0 0
1234
Accounts Payable -14.7 0 -14.7 0 0 0 0
1234
Deferred Revenue 39.59 10.91 -1.81 29.85 0.646 -40.36 10.49
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities 36.82 -119.2 69.98 -19.75 105.8 -161.6 -126.9
1234
Investments in Property Plant and Equipment -0.651 -0.074 -0.117 -0.206 -0.254 -0.219 -0.707
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities -1,022 -334.1 -215.1 -205.7 -266.9 -409.1 -476
1234
Sales and Maturities of Investments 1,084 214.9 310.2 186.2 373 247.7 349.8
1234
Other Investing Activities -25 0 -25 0 0 0 0
1234
Cash From Financing Activities 326.5 296.8 2.26 10.59 16.88 9.64 -0.466
1234
Debt Repayment 0 0 0 0 0 0 0
1234
Common Stock Issued 303.8 278.1 2.26 8.52 14.96 6 -1.01
1234
Common Stock Repurchased 0 0 0 0 0 0 0
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities 22.65 18.66 0 2.07 1.92 3.64 0.546
1234
Effect of Forex Changes on Cash 0.007 -0.027 0.08 0.041 -0.087 0.075 0.002
1234
Net Change in Cash -11.76 92.88 -41.56 -63.07 72.59 -258.8 -223
1234
Cash at Beginning of Period 309.8 205.1 238.7 309.8 237.2 496 718.9
1234
Cash at End of Period 298 298 197.1 246.7 309.8 237.2 496
1234
Free Cash Flow -303.1 -84.71 -114 -54.15 -50.28 -107.1 -96.29
1234
Operating Cash Flow -302.5 -84.63 -113.9 -53.95 -50.03 -106.9 -95.58
1234
Capital Expenditure -0.651 -0.074 -0.117 -0.206 -0.254 -0.219 -0.707
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program